Skip to main content

Publisher: Wiley-Blackwell

Volume 11, Number 12, December 2009

Favourites:
ADD

The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance
pp. 1100-1113(14)
Authors: Kirkham, S.; Akilen, R.; Sharma, S.; Tsiami, A.

Favourites:
ADD

Rediscovering bile acid sequestrants
pp. 1114-1121(8)
Authors: Bell, D. S. H.; O’Keefe, James H.

Favourites:
ADD

Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting
pp. 1122-1130(9)
Authors: Brixner, D. I.; McAdam-Marx, C.; Ye, X.; Boye, K. S.; Nielsen, L. L.; Wintle, M.; Misurski, D.; Fabunmi, R.

Favourites:
ADD

The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics
pp. 1131-1137(7)
Authors: Kazda, C.; Gallwitz, B.; Simó, R.; Guzmán, J. R.; Kraus, P.; Nicolay, C.; Rose, L.; Schernthaner, G.

Favourites:
ADD
Favourites:
ADD

Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia
pp. 1145-1152(8)
Authors: Rosenstock, J.; Rendell, M. S.; Gross, J. L.; Fleck, P. R.; Wilson, C. A.; Mekki, Q.

Favourites:
ADD

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
pp. 1163-1172(10)
Authors: Jendle, J.; Nauck, M. A.; Matthews, D. R.; Frid, A.; Hermansen, K.; Düring, M.; Zdravkovic, M.; Strauss, B. J.; Garber, A. J.

Favourites:
ADD

A1C and weight outcomes at 18 months in patients with type 2 diabetes treated with exenatide in an ambulatory care setting
pp. 1173-1174(2)
Authors: McAdam-Marx, C.; Ye, X.; Brixner, D. I.; Fabunmi, R.; Wintle, M.; Boye, K. S.; Misurski, D.; Nielsen, L. L.

Favourites:
ADD

Erratum
pp. 1175-1175(1)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more